Stay Connected - Sign up for updates on the China Healthcare Summit 2022

China Healthcare Summit 2021 Details -
How will China innovators impact the global biotech and medtech industries?

For seven years, the China Healthcare Summit has been building the "Bridge to Innovation" in China.

Now, armed with unprecedented funds, Chinese biotechs and medtechs are racing across the Bridge to Innovation.

The 8th BioCentury-BayHelix China Healthcare Summit is a propitious time to show how the China story promises to have a lasting impact on the global biopharma industry.

This years Summit will include:

  • Two days of strategic panels on how China innovators will impact the global biotech and medtech industries.
  • 1x1 meetings (in-person or virtual; start requesting meetings with potential investors and partners on Oct. 11.)
  • Two exclusive conference reports on the China biotech and medtech ecosystems from Insights Partner McKinsey & Co.
  • 50+ Road Show Presentations from China, Asia and Western life sciences companies.

Download Event Brochure & Schedule-at-a-GlanceKeep up to date

China Summit Highlights: Day 2 Podcast

Organizing Committee

Chair: Steve Yang, Ph.D.
Co-CEO
WuXi AppTec
Tony Chen
Partner
Jones Day
Franck Le Deu
Senior Partner & Head of Greater China Healthcare Practice
McKinsey & Co.
Debra Yu, M.D.
President & Chief Strategy Officer
LianBio
David Flores
Co-Founder, President & CEO
BioCentury Inc.
Yong Ben, M.D.
Clinical Advisor
BeiGene Ltd.
Moreright-arrow

Speakers

Vivian Bian
China GM
Roche AG
Tony Chen
Partner
Jones Day
Franck Le Deu
Senior Partner & Head of Greater China Healthcare Practice
McKinsey & Co.
Nisa Leung
Managing Partner
Qiming Venture Partners
Steve Yang, Ph.D.
Co-CEO
WuXi AppTec
Karen Bernstein, Ph.D.
Co-Founder & Chairman
BioCentury Inc.
Moreright-arrow

Sponsors

Moreright-arrow
Sponsorship Opportunities AvailableSpeak with a BioCentury representative today

Presenting Companies

Moreright-arrow
Interested in becoming a Presenting Company?Apply now to be considered for the China Healthcare Summit Class of 2021

Testimonials

“The healthcare industry has seen a wave of innovation and development since the COVID-19 pandemic. The new era, that comes with uncertainties and macroeconomic headwinds, requires CEOs, entrepreneurs, and all to communicate effectively and embrace innovation. BioCentury and BayHelix put together a high-quality program that really captures the latest industry trends and offers a valuable opportunity to connect with thought leaders in the region. We look forward to continuing to support the BioCentury-BayHelix China Healthcare Summit, as we have in the past, and sharing our insights at the event.”

Nisa Leung
Managing Partner
Qiming Venture Partners

"The BioCentury & BayHelix China Healthcare Summit has grown from strength to strength over the last eight years. It has become the reference China event for the biopharma community, with an increasingly global audience. As McKinsey, we are proud of our contribution to the Summit as Insights Partner, with our series of reports on “Building Bridges to Innovation”. We look forward to the ninth edition of the event. Given the current context around biotech and the biopharma industry, we expect the event to be once again a great gathering of minds to crystalize trends and shape the journey together."

Franck Le Deu
Senior Partner & Head of Greater China Healthcare Practice
McKinsey & Co.